A Phase 1 TR-701 FA Study of Blood Pressure Response Post Tyramine Challenge

Conditions

• Healthy Volunteers

Interventions

• DRUG: TR-701 FA with Tyramine
• DRUG: Placebo-controlled withTyramine

Sponsor

Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)